Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.
Latest website image capture
Clouds background image

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.8%
    Check dated 2025-06-20T19:21:00.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:11:08.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:58:03.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:46:11.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:07:22.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:14:55.000Z thumbnail image

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.